| A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer F Aminkeng, AP Bhavsar, H Visscher, SR Rassekh, Y Li, JW Lee, ... Nature genetics 47 (9), 1079-1084, 2015 | 284 | 2015 |
| Genetic architecture of schizophrenia: a review of major advancements SE Legge, ML Santoro, S Periyasamy, A Okewole, A Arsalan, K Kowalec Psychological medicine 51 (13), 2168-2177, 2021 | 142 | 2021 |
| Comorbidity increases the risk of relapse in multiple sclerosis: a prospective study K Kowalec, KA McKay, SB Patten, JD Fisk, C Evans, H Tremlett, ... Neurology 89 (24), 2455-2461, 2017 | 129 | 2017 |
| DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia E Hannon, EL Dempster, G Mansell, J Burrage, N Bass, MM Bohlken, ... Elife 10, e58430, 2021 | 112 | 2021 |
| Genetic heterogeneity and subtypes of major depression TD Nguyen, A Harder, Y Xiong, K Kowalec, S Hägg, N Cai, ... Molecular psychiatry 27 (3), 1667-1675, 2022 | 87 | 2022 |
| Interaction testing and polygenic risk scoring to estimate the association of common genetic variants with treatment resistance in schizophrenia AF Pardiñas, SE Smart, IR Willcocks, PA Holmans, CA Dennison, ... JAMA psychiatry 79 (3), 260-269, 2022 | 73 | 2022 |
| Comorbidity is associated with disease activity in MS: findings from the CombiRx trial A Salter, K Kowalec, KC Fitzgerald, G Cutter, RA Marrie Neurology 95 (5), e446-e456, 2020 | 62 | 2020 |
| Etiology, effects and management of comorbidities in multiple sclerosis: recent advances RA Marrie, JD Fisk, K Fitzgerald, K Kowalec, C Maxwell, D Rotstein, ... Frontiers in immunology 14, 1197195, 2023 | 55 | 2023 |
| A systematic review and analysis of the use of polygenic scores in pharmacogenomics D Johnson, MKAP Wilke, SM Lyle, K Kowalec, A Jorgensen, GEB Wright, ... Clinical Pharmacology & Therapeutics 111 (4), 919-930, 2022 | 46 | 2022 |
| Genetic diversity of hepatitis B virus genotypes B6, D and F among circumpolar indigenous individuals K Kowalec, GY Minuk, ML Børresen, A Koch, BJ McMahon, B Simons, ... Journal of Viral Hepatitis 20 (2), 122-130, 2013 | 42 | 2013 |
| Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis K Kowalec, GEB Wright, BI Drögemöller, F Aminkeng, AP Bhavsar, ... Nature genetics 50 (8), 1081-1085, 2018 | 41 | 2018 |
| Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study K Kowalec, Y Lu, A Sariaslan, J Song, A Ploner, C Dalman, CM Hultman, ... Molecular psychiatry 26 (8), 4487-4495, 2021 | 38 | 2021 |
| Molecular characterization of hepatitis B virus and a 9‐year clinical profile in a patient infected with genotype I C Osiowy, K Kaita, K Solar, K Mendoza Journal of medical virology 82 (6), 942-948, 2010 | 38 | 2010 |
| Psychotropic medication use before and during COVID-19: a population-wide study C Leong, K Kowalec, S Eltonsy, JM Bolton, MW Enns, Q Tan, ... Frontiers in Pharmacology 13, 886652, 2022 | 35 | 2022 |
| CIHR Team in Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS) Comorbidity increases the risk of relapse in multiple sclerosis K Kowalec, KA McKay, SB Patten, JD Fisk, C Evans, H Tremlett, ... Neurology 89 (24), 2455-2461, 2017 | 25 | 2017 |
| Methylation age acceleration does not predict mortality in schizophrenia K Kowalec, E Hannon, G Mansell, J Burrage, APS Ori, RA Ophoff, J Mill, ... Translational Psychiatry 9 (1), 157, 2019 | 23 | 2019 |
| Epidemiological overview of major depressive disorder in Scandinavia using nationwide registers JA Pasman, JJ Meijsen, M Haram, K Kowalec, A Harder, Y Xiong, ... The Lancet Regional Health–Europe 29, 2023 | 20 | 2023 |
| Mendelian randomization provides no evidence for a causal role in the bidirectional relationship between depression and multiple sclerosis A Harroud, RA Marrie, KC Fitzgerald, A Salter, Y Lu, M Patel, K Kowalec Multiple Sclerosis Journal 27 (13), 2077-2084, 2021 | 19 | 2021 |
| The impact of educational attainment, intelligence and intellectual disability on schizophrenia: a Swedish population-based register and genetic study J Song, S Yao, K Kowalec, Y Lu, A Sariaslan, JP Szatkiewicz, H Larsson, ... Molecular psychiatry 27 (5), 2439-2447, 2022 | 17 | 2022 |
| Prevalence and risk factors of substance use disorder in inflammatory bowel disease H Carney, RA Marrie, JM Bolton, SB Patten, LA Graff, CN Bernstein, ... Inflammatory Bowel Diseases 27 (1), 58-64, 2021 | 17 | 2021 |
Bruce CarletonUniversity of British ColumbiaGeverifieerd e-mailadres voor popi.ubc.ca
